Journal of Swasthavritta and Yoga · Jul 2026

Integrating Ayurvedic preventive medicine (Swasthavritta) into global NCD control programs: Opportunities and challenges

By Bele SD, Hadke A, Jain M

Noncommunicable diseases (NCDs) principally cardiovascular disease, cancer, chronic respiratory disease, and diabetes are now the leading cause of death worldwide, accounting for at least 43 million deaths annually and imposing a disproportionate burden on low- and middle-income countries (WHO, 2025). Despite the World Health Organization's Global Action Plan for NCDs and the associated "best buy" interventions, progress toward the 2030 global targets has stalled, prompting renewed interest in low-cost, scalable, behaviourally grounded preventive strategies. Swasthavritta, the branch of Ayurveda dedicated to preventive and promotive health, offers a codified system of daily (Dinacharya) and seasonal (Ritucharya) regimens, dietary science (Ahara), ethical conduct (Sadvritta), rejuvenation therapy (Rasayana), and mind-body practices (Yoga, Pranayama, Dhyana) that map closely onto the modifiable behavioural risk factors targeted by contemporary NCD control programs. This article synthesises the conceptual foundations of Swasthavritta, reviews the emerging clinical evidence base for its component practices particularly yoga and meditation in modifying cardiometabolic risk factors, and examines the global policy architecture, led by the World Health Organization's Global Traditional Medicine Strategy 2025–2034 and India's Ministry of AYUSH, that is beginning to formalise the integration of traditional preventive medicine into mainstream health systems. We propose a four-tier framework (global policy, national health system, primary health care/community, and individual/household) for embedding Swasthavritta-based interventions within existing NCD control infrastructure, and we identify the principal opportunities (cost-effectiveness, scalability, cultural acceptability, convergence with chronobiology and lifestyle-medicine science) and challenges (methodological heterogeneity, regulatory fragmentation, workforce gaps, and the risk of unregulated claims) that will determine whether this integration can be achieved safely and effectively. We conclude that Swasthavritta cannot substitute for pharmacological and structural NCD interventions but can meaningfully complement them, provided that integration is guided by rigorous research, transparent regulation, and respect for both traditional knowledge and biomedical evidence standards.

doi.org/10.33545/30787157.2026.v3.i2.a.46Open accessInterventions

AgingResearch.News